Latest News and Press Releases

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...

NEW YORK, 25 juin 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome...

Cosmos Health advances its wholly owned CCX0722 hydrogel weight management patent application across the U.S., Europe, Australia, and Canada.

CALGARY, AB, June 25, 2026 (GLOBE NEWSWIRE) -- Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today...

Labviva launched The Agentic Crew, an AI architecture pairing specialized agents with an LLM orchestrator to automate life sciences R&D procurement.

NeOnc (NASDAQ: NTHI) is entering one of the most significant periods after securing its second IND from the UAE

CTA Approval from Germany's Federal Institute for Drugs and Medical Devices (BfArM), accompanied by a positive opinion from the Ethics Committee of the North Rhine Medical Association, clears Silexion...

Quoin Pharmaceuticals receives FDA conditional approval of QYLEKI as the proposed brand name for QRX003 for Netherton Syndrome.

NeOnc’s (NASDAQ: NTHI) recent Abu Dhabi IND authorization for NEO212 highlights an increasingly attractive pharmaceutical industry development strategy

Initiative creates new resource to support and accelerate early-stage therapeutics companies Parexel forms inaugural partnership with Durham-based Cape Fear BioCapital to connect incubator to a...